Boryung Corporation (KRX:003850)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,050
+70 (0.70%)
At close: Apr 28, 2026
17.96%
Market Cap 849.03B
Revenue (ttm) 1.02T
Net Income (ttm) 64.30B
Shares Out 84.48M
EPS (ttm) 765.85
PE Ratio 13.12
Forward PE 22.43
Dividend 100.00 (1.00%)
Ex-Dividend Date Dec 29, 2025
Volume 103,146
Average Volume 189,605
Open 10,010
Previous Close 9,980
Day's Range 9,960 - 10,090
52-Week Range 8,080 - 10,800
Beta 0.35
RSI 56.19
Earnings Date May 15, 2026

About Boryung

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, and diabetes drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1957
Employees 1,533
Stock Exchange Korea Stock Exchange
Ticker Symbol 003850
Full Company Profile

Financial Performance

In 2025, Boryung's revenue was 1.02 trillion, an increase of 0.03% compared to the previous year's 1.02 trillion. Earnings were 64.30 billion, a decrease of -7.65%.

Financial Statements

News

There is no news available yet.